Gossamer Bio (GOSS) Profit Metrics
Price: $0.94
Market Cap: $213.91M
Avg Volume: 1.48M
Market Cap: $213.91M
Avg Volume: 1.48M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Profit Metrics Summary (Annual)
According to Gossamer Bio's latest annual financial reports:
- The company has reported a gross profit of 114.70M, indicating the amount earned after deducting the cost of goods sold (COGS) from revenue. The gross profit margin is 100.00%, with a year-over-year growth of 2715.76%.
- Gossamer Bio's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -39.97M. The EBITDA margin stands at -34.84%, showing a growth of 76.78% compared to the previous year.
- The operating income, representing the profit from business operations before taxes and interest, stands at -59.92M. The operating margin is -52.24%, with a year-over-year growth of 67.39%.
- The net income, which shows the company's total earnings or profit after all expenses, is -56.53M. The net profit margin is -49.28%, demonstrating a growth of 68.56% from the previous year.
These metrics provide a comprehensive overview of Gossamer Bio's profitability and operational efficiency over the past year.
Gross Profit
$114.70M
Gross Profit Margin (2023)
100.00%
EBITDA
$-39.97M
EBITDA Margin
-34.84%
Operating Income (2023)
$-59.92M
Operating Margin
-52.24%
Net Income
$-56.53M
Net Profit Margin
-49.28%
Historical Gross Profit
Historical Gross Profit Margin
Historical Gross Profit Growth
Historical EBITDA
Historical EBITDA Margin
Historical EBITDA Growth
Historical Operating Income
Historical Operating Profit Margin
Historical Operating Income Growth
Historical Net Income
Historical Net Profit Margin
Historical Net Income Growth
Gossamer Bio Historical Profit Metrics
Gossamer Bio Historical Profits
The table below shows various profit metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Gross Profit | Gross Profit Growth | Operating Income | Operating Income Growth | Net Income | Net Income Growth | EBITDA | EBITDA Growth |
|---|---|---|---|---|---|---|---|---|
| 2024 | $114.70M | 2715.76% | $-59.92M | 67.39% | $-56.53M | 68.56% | $-39.97M | 76.78% |
| 2023 | $-4.38M | 0.99% | $-183.76M | 15.94% | $-179.82M | 25.15% | $-172.15M | 18.44% |
| 2022 | $-4.43M | 14.28% | $-218.59M | -1.14% | $-240.23M | 3.55% | $-211.07M | -0.83% |
| 2021 | $-5.17M | -21.06% | $-216.12M | 7.62% | $-249.08M | 1.00% | $-209.32M | 10.53% |
| 2020 | $-4.27M | -38.17% | $-233.96M | -25.69% | $-251.58M | -39.14% | $-233.96M | -25.69% |
| 2019 | $-3.09M | -940.07% | $-186.14M | -24.93% | $-180.82M | -23.03% | $-186.14M | -24.93% |
| 2018 | $-297.00K | 0.00% | $-148.99M | -2139.49% | $-146.97M | -2070.57% | $-148.99M | -2139.49% |
| 2017 | $- | 0.00% | $-6.65M | -7915.66% | $-6.77M | -8057.83% | $-6.65M | -7915.66% |
| 2016 | $- | 0.00% | $-83.00K | 0.00% | $-83.00K | 0.00% | $-83.00K | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for GOSS.